NICE said the drug was not recommended for women with breast cancer, other oestrogen-dependent cancers or liver disease because these groups were not included in clinical trials of the drug. As a result, there is no data available on the risks or benefits to these women.
Фото: Matt Rourke / Reuters，更多细节参见TG官网-TG下载
。关于这个话题，手游提供了深入分析
Talk to an expert
Стало известно возможное наказание Верке Сердючке в России20:50。关于这个话题，超级权重提供了深入分析